Figueira Edwin, Rajak Saul, McKelvie Penny, Kalantzis George, Ismail Azzam, Gonzales Michael, James Craig, McNab Alan, Selva Dinesh
a South Australian Institute of Ophthalmology , Royal Adelaide Hospital , Adelaide , Australia.
b Department of Ophthalmology , Prince of Wales Hospital , Randwick , NSW , Australia.
Orbit. 2018 Oct;37(5):352-357. doi: 10.1080/01676830.2017.1423354. Epub 2018 Feb 1.
Primary orbital melanoma (POM) is a very rare condition. We report further four cases and review all previously reported cases. We present a multicentre retrospective review of patients with POM. Clinical, radiological, surgical, histological, and follow-up data is presented. Four patients with POM were identified between 2000 and 2013. All presented with proptosis and diplopia without reduced vision. Two had known pre-existing blue cell naevi. All were stage T1N0M0. All underwent exenteration with adjuvant radiotherapy. All are disease free at follow-up durations of 24-151 months. The present three cases and review of all cases in the literature suggest a higher likelihood of disease-free survival from primary exenteration (7/8 disease-free survival, 1/8 death from metastatic disease) than wide local excision (7/16 disease-free survival, 9 recurrence or metastasis of whom 4 died). Adjuvant radiotherapy may additionally improve outcomes.
原发性眼眶黑色素瘤(POM)是一种非常罕见的疾病。我们报告另外4例病例,并对所有先前报道的病例进行回顾。我们对POM患者进行了多中心回顾性研究。呈现了临床、放射学、手术、组织学及随访数据。2000年至2013年间确诊了4例POM患者。所有患者均表现为眼球突出和复视,但视力未下降。2例患者既往已知有蓝色细胞痣。所有患者均为T1N0M0期。所有患者均接受了眶内容剜除术及辅助放疗。在24至151个月的随访期内,所有患者均无疾病复发。目前的3例病例及对文献中所有病例的回顾表明,与广泛局部切除相比,原发性眶内容剜除术的无病生存率更高(8例中有7例无病生存,1例因转移性疾病死亡)(16例中有7例无病生存,9例复发或转移,其中4例死亡)。辅助放疗可能会进一步改善治疗效果。